Physician Survey to Assess the Effectiveness of the Additional Risk Minimisation Measures (aRMM) for KIMMTRAK® (tebentafusp) (IMCR-0001) First published 12/12/2023 Last updated 12/12/2023 EU PAS number:EUPAS107979 Study Ongoing